Cooperative Agreement U2GPS002909

This Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,251,196 to the University of Washington to scale up an evidence-based Adolescent Transition Package (ATP) to support transitional care for youth living with HIV in Kenya. The project aims to compare two implementation strategies for scaling up the ATP: the standard Kenya Ministry of Health approach versus an enhanced strategy that incorporates...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) totaling $582,959 will fund a pilot study to integrate a "Universal Test and Connect" (UTC) HIV service delivery strategy in emergency care settings in South Africa. The goal is to expand access to both preventative (pre- and post-exposure prophylaxis) and therapeutic (ART initiation) HIV services through the emergency department,...

This Cooperative Agreement, awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB testing; 2) increase coverage and timeliness of viral load, early...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) provides $15,351,606 to Cicatelli Associates, Inc. (CAI) to strengthen the capacity of health departments, community-based organizations, and the broader HIV prevention workforce. Specifically, CAI will deliver training and technical assistance services focused on promoting the adoption, implementation, and...

The San Francisco Department of Public Health's Center for Learning & Innovation was awarded a $4,989,475 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). Through this 5-year award, the organization will provide tailored technical assistance and capacity building services to health departments, community-based organizations, and other HIV prevention partners...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $637,749 to the University of Illinois to evaluate the effectiveness of an assisted partner notification (APN) intervention, called IMPART, to increase HIV testing and diagnosis among partners of incarcerated people with HIV in Indonesia. The IMPART model trains community health workers to work in prisons and coach inmates to either...

This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund a pragmatic pilot feasibility trial to assess the clinical and implementation outcomes of using point-of-care sexually transmitted infection (STI) testing to improve HIV prevention service delivery in adolescents. The $223,550 award, effective June 9, 2025 through June 8, 2027, will be provided to the Icahn School of Medicine at Mount...